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Hydroxyurea  Affects  Cell  Morphology,  Cation  Transport,  and  Red  Blood  Cell 
Adhesion  in  Cultured  Vascular  Endothelial  Cells 
By Norma C.  Adragna, Peter Fonseca, and Peter K. Lauf 
Hydroxyurea (HU) significantly increases fetal hemoglobin 
(Hb) production and concomitantly affects passive  erythro- 
cyte K transport and cell volume in patients homozygous 
for Hb S, thus decreasing disease severity. Red blood cells 
(RBCs) with Hb S display a greater adherence  to  vascular 
endothelial cells (VECs) than do Hb A cells, thus increasing 
the probability of vaso-occlusive crisis. The effect  of  HU on 
the structure and function of VECs is  still  unknown. In the 
present study, HU significantly changed, in a  dose-depen- 
dent manner, the morphology and monovalent cation com- 
position of cultured VECs after incubation in normal culture 
medium for up to 10 days in the absence and presence of 
0.3 (therapeutic dose) and 3.0 (toxic dose) mmol/L  HU. 
Treated  cells  showed  significant  morphologic  changes 
such as an increase in apparent cell size and the  formation 
H 
YDROXYUREA (HU) has been  shown  to increase 
fetal  hemoglobin (Hb F) production significantly in 
patients with  sickle  cell  anemia.’”  Epidemiologic studies 
show that high  levels of Hb F are associated  with  reduced 
disease ~everity~’~?’  and potentially may  decrease the num- 
ber  of  vaso-occlusive crise~.~.~  Administration of HU  to  pa- 
tients with  severe  cases  of  sickle  cell  anemia increases Hb F, 
F reticulocyte count, Hb F red blood cells  (RBCs),  mean 
corpuscular volume, RBC  survival,  oxygen  affinity,  and to- 
tal RBC cation content, with  additional improvement of 
RBC deformability and its hydration status.’” In contrast, 
mean corpuscular Hb concentration, hemolysis, percent of 
irreversibly  sickled  RBCs, and, notably, KC3 cotransport are 
decreased by treatment with the drug.4~~ 
HU, an antitumor agent, inhibits DNA  synthesis by de- 
stroying the tyrosyl  free  radical  of  the M2 subunit of the 
enzyme ribonucleotide reductase. This enzyme catalyzes 
the formation of deoxyribonucleotides  from ribonucleoside 
diphosphate precursors and is a rate-limiting step in  DNA 
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Fig 1.  Protein  content  per  dish  of bovineVEC.  line  BFAE-39  as  a 
function of HU concentration  after  3  days  of  culture.  HU  was added 
to  the  culture  medium  during  cell  seeding.  Results  are  protein 
contents  per  dish  of three  independent  experiments  (CONT  = con- 
trol; 0.3  HU = 0.3  mmol/L HU; 3  HU = 3  mmol/L HU) with cells at 
passages 3 and 6. Values  are  expressed as X f  SD  (n = 3  dishes 
per  condition). 
of multinucleated  giant  cells. The protein  content  per dish 
decreased  by 50%  and 80%  at  0.3  and 3.0  mmd/L HU, re- 
spectively, accompanied by an increase in cell Na (maxi- 
mum, -200%) and cell K (maximum, -50%) contents at 
about days 4 to 6 and 8 to 10. respectively. In addition. 
HU  decreased RBC adherence  toVECs in  experiments with 
6’Cr-loaded Hb  A or Hb S RBCs. The HU-induced  changes 
in VEC  morphology, cation composition, and RBC adher- 
ence may be caused or accompanied by alterations in cell 
membrane  permeability,  transformation  of  endothelial 
cells,  or  decreased  number/density of VEC adhesion mole- 
cules. Precise mechanisms of the HU effects warrant  fur- 
ther  investigation  in light of the reported beneficial effects 
of HU in  the  treatment  of  sickle cell anemia. 
Q 1994 by The American Society of  Hematology. 
synthesk8  In addition, DNA  synthesis has been  associated 
with  an increase  in  Na  influx,  Na/K  pump activity, Ca 
efflux, and intracellular pH  (pHi)  in  cultured fibroblasts.’ 
Furthermore, HU (  l mmol/L) has been  used  to synchronize 
cultured  bovine aortic endothelial cells.”  However,  the 
effect of HU on DNA synthesis and cell  cycle  progression 
depends on its concentration, treatment times, and other 
unknown factors.’  I 
The mechanism of vaso-occlusion  involves  blood  cells, 
vascular endothelial cells  (VECs), and plasma factors.  Re- 
cent studies have demonstrated that RBCs with Hb S  adhere 
better to endothelial cells than do RBCs  with  Hb  and 
that this effect is increased  in  the presence of autologous 
plasma’”’6 or autologous platelets.16  Adhesion of erythro- 
cytes and other blood  cells appears to induce local  hypoxia 
and stasis,  which  lead  to vaso-occlusion  when  accompanied 
by vasoconstriction. In addition, hypoxia induces the pro- 
duction of  platelet-derived  growth  factor (PDGF)  and endo- 
thelin, two potent vasoconstrictors  secreted  by VECs.”~’* 
In  light of the above information, the present study was 
designed to assess the effect of HU on VEC function, which, 
as in other cells  (RBCs and fibroblasts), should be  reflected 
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Fig 2.  Effect of HU on VEC 
morphology. (A) Control  cells at 
passage 3  after 10 days in cul- 
ture and in the absence of HU 
were approximately 90% con- 
fluent,  with  some  cells  un- 
dergoing  division.  Aging of the 
cultures was manifested  by the 
presence of vacuoles. (B) Cells 
were cultured for 10 days and 
treated  for  7  days  with 0.3 
mmol/L HU; cultures are at ap- 
proximately  60% confluence. 
Note the larger cell size,  more 
binucleated  cells,  and  the larger 
and higher number  of  vacuoles 
than in  control cells. 
in  morphologic  and  biophysical  properties,  as well  as in 
RBC adhesion. 
MATERIALS  AND  METHODS 
Materials.  The endothelial cell line BFAE-39 originated  from 
bovine thoracic  aorta of normal 4- to 5-month-old male  fetuses(AG 
07680, NIA  Aging  Cell  Repository,  Coriell  Institute for  Medical  Re- 
search, Camden, NJ). Media and chemicals  used  were  as follows: F- 
12 nutrient mixture (Ham, HF12). cell culture media supplements, 
trypsin,  penicillin,  streptomycin, amphotericin  B,  and  EDTA 
(GIBCO, Grand Island, NY); defined  fetal  bovine  serum  (Hyclone 
Laboratories.  Logan,  UT);  bovine  serum  albumin (catalog  no. 
A7030).  tris(hydroxymethy1)aminomethane base (Tris), and  HU 
(Sigma  Chemical,  St  Louis.  MO);  and  Dulbecco's  phosphate- 
buffered  saline and Hanks balanced salt solution  without  calcium 
and magnesium (Hanks medium [HMI, Whittaker, M.A.  Biopro- 
ducts, Walkersville,  MD). 
Cell culiwe.  Bovine aortic endothelial cells  were  propagated  in 
HF12  (passages  3 through  6, cumulative population doubling 
[CPD]  30) supplemented with antibiotics and 10% fetal  bovine 
serum. Cells  were  subcultured  with trypsin-EDTA  asdescribed  else- HYDROXYUREA  EFFECTS  ON  VASCULAR  ENDOTHELIUM  555 
Fig  2.  (Cont'd)  (C)  Cells 
were cultured for 10 days  and 
treated  for  7  days  with  3.0 
mmol/L HU;  cultures  are  at ap- 
proximately 30% to 40% ron- 
fluence. Note the  larger cell size 
and higher number of binucle- 
ated  and  trinucleated  cells as 
compared  with  A and B; how- 
ever,  the number  of  vacuoles 
was  smaller than in B. (Original 
magnification X 200;  Nikon Di- 
Phot microscope; Nikon,  Tokyo, 
Japan.) 
where,I9 and passaged at a  1:2  or  1:5  ratio in 81-cm2 flasks. For 
cation  transport  measurements,  cells were cultured in 35-mm di- 
ameter dishes, fed every other day, and used after 2 to I  I  days in 
culture. The  splitting  ratios  were one 25-cmz flask into I5  dishes or 
one  81cm2  flask into 50 dishes; three  dishes per point were used. 
For experiments  on RBC-endothelial  cell  adhesion,  cells  were 
seeded in  six-well  plates of 35-mm diameter  (Costar,  Cambridge, 
MA) and used after confluence (between 5 and  I2 days  after seed- 
ing). 
HU treatment.  HU was added to the culture medium  either 
during  or  2 days after cell seeding, at final concentrations  of 0.3 or 
3.0 mmol/L  to  simulate  therapeutic  and toxic doses, respectively. 
Endothelial cell cation and prolein determinalions.  Na and K 
levels were determined  by  atomic absorption  spectrophotometry 
(Perkin Elmer 5000; Perkin Elmer-Cetus, Norwalk, CT),  and pro- 
tein content was determined by the  method of Lowry et al, as de- 
scribed previously." 
RBC  adhesion to  VECs.  The methods  of  Hebbel et  allz  and 
Wautier et all3  were used with some modifications, as described be- 
low, to determine RBC adhesion to VECs. 
RBC  loading with "Cr.  Blood was obtained by  venipuncture 
into heparinized vacuum  tubes  from two healthy individuals  (ho- 
mozygous for Hb A) and from two individuals with sickle cell dis- 
ease (homozygous for Hb  S. courtesy of Dr D. Rucknagel, Compre- 
hensive Sickle Cell Center, University  of  Cincinnati,  College of 
Medicine, Cincinnati, OH)  and  processed within  I  to 2 hours. After 
centrifugation for  IO minutes  at 3,000~  and 4°C. the whole-blood 
sample was divided into  three fractions, plasma, buffy coat resus- 
pended in plasma, and packed RBCs. The first two  fractions were 
maintained on  ice while the RBCs were washed three  times  with an 
isotonic phosphate-buffered saline  solution  containing the follow- 
ing (mmol/L):  137 NaCI,  2.7  KCI,  0.9  CaCIz, 0.5  MgCIz,  8.1 
NaZHPO4,  and 1.5 KHZPO4.  After the last wash, packed cells were 
resuspended  at  approximately  50%  hematocrit  in  phosphate- 
buffered saline and labeled for 40 minutes at 37°C  with S'Cr(sodium 
chromate,  Amersham,  Arlington Heights, IL; 50 pCi/mL packed 
RBCs). The labeled RBCs were washed an additional  three  times 
with HM. divided into three aliquots, washed once more, and re- 
suspended  to hematocrit 25% (vol/vol) in either HM containing 
0.5% bovine  serum  albumin.  plasma alone, or plasma containing 
the buffy coat. 
RBC  adhesion.  Because adherence  of endothelial cells appears 
to be independent of the species.14  we used VECs of bovine origin 
(cell line BFAE-39). Endothelial cells cultured in  six-well  plates to 
confluence and in the presence or absence of HU were washed twice 
in HM with 0.5% bovine serum  albumin.  Labeled RBCs (0.7 mL 
of 25% [vol/vol] suspension) were layered on  duplicate wells and 
incubated for 30  minutes  at 37°C. After incubation,  nonadhered 
cells were removed by aspiration. and  the  cultures were washed  five 
times with 0.7-mL  aliquots of HM with albumin and once with 
distilled  water  to remove  residual  radioactivity  (from  adhered 
RBCs) in the plates. Radioactivity from each  sample  was measured 
in a  Packard  Auto-Gamma  5650  counter (Packard  Instrument, 
Downers  Grove,  IL). Results were expressed as the percentage of 
total radioactivity that remained in the  cultures after each wash, as 
described by Wautier et al." 
Statis~ics. Results are expressed as the  mean  f  standard devia- 
tion (X 2 SD). Statistical significance was assessed by two-sample 
paired or unpaired I test analysis with computer software. 
RESULTS 
Exposure qf  endothelial cells to HU before and after cell 
auachment.  Seeding of VECs in the presence of HU de- 
creased the protein content per dish after 3 days of culture 
in  a  dose-dependent  manner (Fig  1) with no effect on Na 
and K contents  (data not shown). Figure  I  shows three in- 
dependent experiments, two of them on VECs at passage 6 
and  one at passage 3. Under these conditions, HU caused, 
again in a dose-dependent  manner, significant changes in 
cell volume and extensive vacuolization associated with ini- 
tial cell death (data not shown). To determine whether HU 
interfered with  cell  attachment, growth, or both, the effect 556 
of HU  on  cell morphology was investigated after cell attach- 
ment. Figure 2A through  C shows the effect of HU  on cell 
morphology when added 2 days  after seeding. Cells at pas- 
sage 3 or 6 were incubated for 10 days in  the  absence (con- 
trol) and presence of 0.3 and 3.0 mmol/L  HU,  respectively. 
HU increased cell volume and caused appearance of binu- 
cleated and trinucleated cells with extensive vacuolization 
(both at passages 3 and 6) in  a  dose-dependent manner (Fig 
2B and C). 
Figure 3 shows a representative experiment  demonstrat- 
ing the effect  of HU, added  2  days  after  seeding, on  the  pro- 
tein content per dish at various days in  culture and in the 
presence or absence of HU.  The  drug decreased the protein 
content per dish after  24  hours of treatment  (day 3 in cul- 
ture), an effect that became dose-dependent after 48 hours 
(day 4  in  culture), reaching a maximum after 9 days of treat- 
ment.  Thus, the effect of HU  on  cell growth was not medi- 
ated by inhibition of  cell  attachment. 
Under  experimental  conditions  identical to those ofFig 3, 
HU increased the  Na  content  of VECs in  a  dose-dependent 
manner between 4 and 8 days in  culture  and partially de- 
creased the peak of Na content characteristic for VECs at 
about 10 to I 1 days of culture19  (Fig 4A). Figure 4B shows 
the typical decrease of cell K content after seeding," which 
was prevented by HU  in  a  dose-dependent manner after day 
4  in  culture,  ie, 2  days  after  HU treatment was started. The 
effect  of  HU  on  total  cation  content  (a measure of  VEC  vol- 
ume) was similar to  that  on  K, the  major osmolyte in these 
cells (Fig 4C). 
A clear insight into  the dynamics of ionic shifts can be 
obtained by plotting the HU-related changes as  a  function 
of time. Figure 5A through  C  shows the mean values of HU- 
dependent  Na,  K, and total  cation  changes, respectively, 
versus days in  culture  from  three  independent  experiments. 
The effect  of HU  on  Na  content was transient, with a maxi- 
mum increase of about 70% at 0.3 mmol/L  and  150%  at 3.0 
mmol/L  HU  between 4 and 7 days in culture (Fig 5A). The 
HU-induced increase of K (Fig 5B) and total  cation  contents 
(Fig 5C) occurred  after  day 4, with a maximum  (up  to  40% 
to 50% at 3.0 mmol/L  HU)  after day 8. Hence, HU caused 
statistically significant and sequential changes in Na and K 
contents of cultured VECs. 
RBC adhesion to HU-treated VECs.  Figure 6 plots the 
percentage of 5'Cr radioactivity associated with VECs in a 
wash-out experiment to determine Hb A RBC adhesion to 
untreated and HU-treated VECs (0.3 mmol/L  HU for 7 
days) for three  conditions  in which cells  were incubated in 
either HM, autologous plasma, or autologous plasma con- 
taining  the buffy coat (for further details, see  legend  to Fig 
6). The rationale for using autologous plasma containing 
white blood cells (in the buffy coat) was to test for competi- 
tion  between  these  and  VECs  for  RBC  adherence.  No 
difference was observed in RBC adhesion to either treated 
or untreated  VECs in buffered saline solution, whereas a 
slight and probably nonsignificant decrease was observed in 
the adhesion of RBCs to HU-treated VECs in autologous 
plasma and plasma containing white blood cells. However, 
in comparison to plasma alone, the presence of white blood 
cells in autologous plasma appeared to produce  a small but 
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significant difference (P  < .05, n = 3 independent experi- 
ments) in  RBC  adhesion, which disappeared as the washing 
procedure  continued. 
Table  l  summarizes the fractional 5'Cr radioactivity re- 
maining  in  VECs during wash-out experiments to deter- 
mine the effect  of HU  on  Hb  A and S RBC adhesion. Mean 
values per  wash  were  calculated  from  three  experiments 
with Hb A and two experiments with Hb S RBCs. On aver- 
age, incubation  in  plasma left higher counts along the wash- 
out curve, although statistical significance was reached only 
for the  first  two washes both  in control  and HU-treated 
VECs. 
Determination  of the radioactivity of hemolysates (ob- 
tained by addition of distilled water to the dishes after the 
five washes were completed) is another means to estimate 
VEC-bound RBC "Cr.  Figure 7  summarizes  the  hemolysate 
counts for the first four  conditions  described in Fig 6 for two 
subjects with Hb A and two subjects with Hb S. For  the  first 
subject with Hb A (A l),  HU  treatment of VECs in culture 
lasted 3 days [A1(3d)]. For  the second Hb A subject (A2), 
the  experiments  were  performed  after  4  [A2(4d)] and 7 
[A2(7d)] days of treatment  with HU. Note that at  day  4 
[A2(4d)] no HU-induced decrease was observed for cells in- 
cubated in HM and only a small decrease (1  8%)  was shown 
by those incubated in autologous plasma, whereas at day 7 
[A2(7d)], HU decreased by  30% and 50% the hemolysate 
counts in cells incubated  in  HM  and plasma, respectively. 
In  light  of  the above findings, VECs  were  treated  for 7 
days with 0.3 mmol/L  HU  to study Hb S RBC adhesion. 
For the first Hb S subject (SI), HU decreased the counts by 
0%  and 20% for cells incubated  in HM  and  plasma, respec- 
tively, and for the second Hb S subject (S2), by  29% and 
58%. Despite the small number of samples, the difference in 
hemolysate radioactivity between control and HU-treated 
endothelial cells incubated in plasma was significant (P < 
.05, n = 5). 
Thus,  the  HU-induced  decrease in  hemolysate  counts 
when  cells  were  incubated  in  either  HM or  autologous 
plasma showed time and interindividual  dependence. The 
time  dependence  is clearly shown for subject A2 when com- 
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Fig 3.  Effect of two HU concentrations on  VEC  protein  content 
per  dish  (at passage 6) as  a  function  of days  in  culture.  Control  (D); 
0.3 mmol/L HU (A); and 3.0 mmd/L HU (0).  Results  are  expressed 
as X 2 SD; errors  not  shown  when smaller than symbols. HYDROXYUREA EFFECTS  ON VASCULAR  ENDOTHELIUM 
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Fig 4.  Effect of HU  on  cation  content  in bovine  aortic  endothelial 
cells after several  days  in  culture.  (A) Na; (B) K;  (C) total cations. 
Cell passage  number, symbols, and  expression of results  are  as in 
Fig 3. 
paring the HU-induced decrease in RBC adhesion in HU- 
treated VECs at days 4 and 7; the longer the treatment, the 
higher the HU-induced decrease. In addition, the length of 
treatment appeared to affect in a similar fashion the HU- 
induced decrease  in  RBC adherence and the changes  ob- 
served  in  cation transport (compare Figs 4, 5, and 7). The 
interindividual dependence is  clearly  shown  when  compar- 
ing the HU-induced decrease after 7 days of VEC treatment 
for subjects A2, S  I, and S2. 
Our results also show that the HU-induced decrease was 
independent of the Hb type. A greater decrease occurred in 
cells incubated in plasma, suggesting a decreased RBC ad- 
hesion to HU-treated VECs. Furthermore, the total number 
of counts remaining after the last wash increased mainly in 
untreated VECs as a function of days in culture, 
In three independent experiments with Hb A RBCs, the 
presence of  white  blood  cells  in  autologous plasma de- 
creased the hemolysate radioactivity from 0.82% *  0.34% 
557 
to 0.34% & 0.16% in control VECs and from 0.56%  -t 0.17% 
to 0.28%  k 0.21%  in HU-treated VECs (P  < .05) suggesting 
competition between VECs and white blood cells  for RBC 
adherence rather than between VECs and platelets,  since  au- 
tologous platelets  from  Hb S but not from Hb A increase 
RBC adhesion.I6 
DISCUSSION 
This study reports for the first time prominent effects ol 
therapeutic and toxic  doses of HU on the morphology  and 
steady-state ionic composition of cultured VECs. The HU- 
induced formation of giant, multinuclear VECs with  re- 
duced  confluency  (Fig  2)  and  hence  decreased  protein 
content per  dish  (Fig  3)  is consistent with the fact that HU 
inhibits DNA synthesis'  and  that large RBCs appear in the 
circulation after HU treatment of Hb S  patient^.^,^ Our data 
rule out interference by HU solely on cell attachment (Fig 
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Fig 6.  HU-dependent  cation  changesin  bovine  aortic  endothelial 
cells as a function of days  in  culture.  (A) Na: (B) K; (C) total cations. 
Cells were at passages 3 through 6. (A) 0.3 mmol/L HU; (0)  3.0 
mmol/L HU. Results  are  expressed  as  X  f  SD; means  represent 
the percent  change in three independent  experiments with tripli- 
cate samples  each. 558  ADRAGNA.  FONSECA.  AND  LAUF 
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Fig 6.  Adhesion  of 6'Cr-labeled  RBCs  from  a  Hb  A  donor to cul- 
tured  bovine  aortic  endothelial  cells  (cell  line  BFAE-39). Results  are 
expressed  as  the mean (n = 2) percentage  of  radioactivity  remain- 
ing after each  wash;  HU  concentration was 0.3  mmol/L.  Cells  were 
cultured  for 10 days  and  treated with  HU  for 7 days. (1) Untreated 
VECs  in the presence  of  Hanks  balanced  salt  solution (U); (2) HU- 
treated  VECs  in  Hanks  (A); (3)  untreated  VECs  in  autologous  plasma 
(0);  (4) HU-treated VECs  in  autologous  plasma  (m);  (5) untreated 
VECs  in  autologous  plasma  containing  white blood  cells  (A);  (6)  HU- 
treated VECs  in  autologous  plasma  containing  white blood  cells  (e). 
3). The substantial changes in cellular morphology may re- 
flect endothelial transformation, failure of cell division (en- 
domitotic reduplication?), cell fusion, or a  combination  of 
these effects, and may be at  the root of or causal to activa- 
tion/inhibition  of ion  transport  pathways as evident from 
the cellular cation changes specifically due  to  HU  treatment 
(Fig 5). 
HU altered the Na and K composition of cultured VECs 
when added  after cell attachment (Figs 4A through C and 
5A through C), but not when added  during  cell seeding (data 
not shown). At  first glance, these results appear to indicate 
that HU affects cation  content differently depending on  the 
time of exposure to  the  drug, ie, before or after cell attach- 
ment occurred. However, when cells  were  exposed to  HU 
during  seeding, the  changes  in  both  protein  and cation 
content  were  studied only after 3 days in  culture  (Fig  1; 
other results not shown). At this  time  point,  Fig  4A through 
C also shows no statistical difference in cation content be- 
tween HU-treated and untreated cells, while the effect ap- 
pears beyond 4  days  in culture.  Thus, the changes in  cation 
content were not  a  consequence of HU effect(s) on cell at- 
tachment,  but  rather  oftime-  and  concentration-dependent 
effect(s) on cellular ionic  transport. 
The increase in Na content was transient and lasted less 
than  72 hours (Figs  4A  and SA). This  phenomenon  may 
underlie an increase in  the passive permeability of VECs to 
Na. Since this effect preceded the changes in K content, it is 
possible that  the increased cellular Na content resulted in 
(1) activation of already-existing Na/K pumps, (2)  synthesis 
of  new pump molecules, (3) a  sum  of these two effects, or (4) 
a mediated passive Na entry  (through Na-K-Cl cotransport 
or Na/H exchange?). Such mechanisms  should  increase cel- 
lular K levels. However, if this was the only mechanism of 
increase in  K  content,  the total  cation content or cell  vol- 
ume would be expected to remain the same or decrease since 
the pump operates at  a 3 Na:2 K stoichiometry. Thus, these 
results suggest that in addition to direct or indirect effects on 
the  Na/K  pump, HU  affects K content  either by inhibiting 
other pathway(s) for  K  exit or by  stimulating alternative 
routes for K influx. The first possibility seems more likely in 
light of the effects  of HU on K-Cl cotransport and cell  vol- 
ume in RBCS.~  Although at this point K-Cl cotransport has 
not been shown in VECs, Fig 4B and unpublished evidence 
from this laboratory points in this direction, since HU in- 
hibited in a dose-dependent  manner  and  as  a  function of 
time in culture  the  normal  decrease in K content reported 
earlier."  This effect  of HU on K content was accompanied 
by an increase of cation  content  and  thus  of  cell  volume (Fig 
4C and K).  which resembles the effects of the  drug  in RBCs 
of patients  under  treatment.''"3 
HU significantly decreased RBC adherence to VECs dur- 
ing analysis of the radioactivity remaining in  the  hemoly- 
sates after the fifth  wash (Fig 7). Furthermore, in 51Cr  wash- 
out  experiments (Fig 6 and Table  l), adhesion of RBCs to 
VECs was higher in the presence of plasma than in HM both 
with or without HU treatment. However, statistical signifi- 
cance was obtained only for the two initial washes, whereas 
the  HU  effect  was  statistically nonsignificant. This result 
may  be  accounted for by several factors. First, the high num- 
ber  of  counts in the wash-out experiments produced a larger 
error than the  one  inherent to  the small number of counts 
extracted in the hemolysate, with the  consequent effect on 
statistical significance. Second, the effect  of  HU was time- 
dependent; however, selection for computation  of the ex- 
periments performed after 7 days of treatment with HU did 
not  improve  the  statistical  significance in  the  wash-out 
curves. Third,  the effect  of  HU on RBC adherence showed 
interindividual variability, suggesting that RBC-VEC adhe- 
sion is a specific process. 
We did not confirm previous findings of increased Hb S 
RBC adherence to VECS,'~"~  which may be due  to  the small 
sample size and interindividual variability.16  The use of bo- 
vine instead of human serum albumin during  the  incuba- 
tions with HM could explain the differences observed be- 
tween  this  medium  and  the  conditions  using  human 
Table 1. Effect  of HU  Treatment on "Cr-Labeled 
RBC  Adherence  to VECs 
Medlurn  Wash No.  Control (%)  HU (%) 










8.5 f  2.5 
4.9 f  1.8 
3.4 t  1.8 
2.6 ? 1.9 
2.2 f  1.8 
12.8 f  3.3' 
8.7 f  2.9t 
6.3 i- 2.4 
5.2 k 2.3 
4.5 f  2.2 
9.1 f  2.6 
4.7 f  1.7 
3.3 2  1.9 
2.7 f  1.9 
2.3 f  1.9 
14.6 k 4.2t 
9.5 k 2.4t 
7.3 t  2.6 
6.4 ? 2.9 
5.8 f  3.2 
Results are presented  as fractional 5'Cr radioactivity  remaining  in  VECs 
after each wash (n = 5, x  f  SD). 
*Pc  .01 with respect to HM. 
t Pc  .05  with respect to HM. HYDROXYUREA  EFFECTS  ON  VASCULAR  ENDOTHELIUM  559 
tance  not  only  for sickle cell anemia, but also for chemo- 
therapy, since cell enlargement seems to be a generalized 
phenomenon induced by HU  and  also by other drugs. HU 
is not only a cytostatic drug, but also a carcinogen. Knowing 
the mechanism of toxicity of the  drug  at  both  cellular and 
molecular levels could provide relevant information for the 
treatment of sickle cell anemia and of cancer  as  well. 
The decrease in RBC adhesion could result either from 
cell enlargement by decreasing the relative density of adhe- 
sion molecules anchoring the RBC, from a drug-induced 
concomitant decrease in the absolute number of adhesion 
molecules, or from HU effects on their  normal  function. A 
combination of all these factors is also possible. These fac- 
tors may appear  as a consequence of (I) changes in  mem- 
brane potential affecting the assembly of the adhesion com- 
plexes that  insert  in  the  membrane,  (2)  altered  surface 
potential, local pH, ionic  microenvironment,  or cell  swell- 
ing, or (3) any other change affecting production of second 
messengers. All of these phenomena can be reflected in an 
altered ion  transport activity of the cell. Understanding  the 
mechanism  of decreased adhesion can provide significant 
information on the process of  RBC-endothelial cell adhe- 
sion that is at the  root of the vaso-occlusive process, which 
is  of  high  significance in sickle cell anemia. 
In conclusion, our results show that  HU induced signifi- 
cant morphologic and  membrane  transport changes in cul- 
tured  VECs.  In  addition,  this  study  provokes interesting 
questions that could stimulate  further studies to determine 
the effect of HU  on  VEC function  in  vivo. 
c  1.20 
8 0.90 









Al(3d)  A2(4d)  A2(7d)  S1  (7d)  S2(7d) 
Fig 7.  Adhesion ol "Cr-labeled RBCs from two Hb  A (Al, A21  and 
two Hb S (Sl, 82) donors to cultured  bovine  aortic  endothelial  cdls 
after  incubation in media  of  different composition.  Results  are 
expressed as the mean (n = 2) percentage  radioactivity  extracted 
after  hemolyzing  the cells in  distilled  water (see the Methods).  Cells 
were cultured  from  5 to 10 days  and  treated  with 0.3  moi/L  HU  from 
3 to 7 days,  as indicated in parentheses in the figure. Untreated 
endothelial  cells  incubated  in HM (m); HU-treated  cells  in  HM I 
control celb incubated in autologous  plasma  (a);  HU-treated  cells  in 
plasma (HI. 
plasma. However, based on  the  finding that bovine and hu- 
man VECs behave similarly for RBC adhesion,14  it is to be 
expected that  the  differences observed between  HM and 
plasma are due  to  the  presence of other plasma  components, 
ie, Ca, growth factors, vasoactive agents, and hormones.12"* 
Our results instead confirm the suggestion by Narla and Ev- 
an~'~  of a lack  of  an effect of plasma-free suspending me- 
dium  on  RBC-VEC adhesion, which was shown by Hebbel 
et  all2 and Antonucci  et  all6 to be due  to a calcium effect. 
Furthermore, our results on RBC adherence to HU-treated 
VECs are commensurate with in vivo studies indicating a 
beneficial effect of HU on  the  mechanism of vaso-occlusion. 
Our results on cell morphology thus appear to indicate 
that by inhibiting DNA synthesis, HU provoked initial cell 
death. However, by an as-yet-unknown mechanism (trans- 
formation?  adaptation?),  the surviving cells were able to 
multiply and grow, although a higher percentage of binucle- 
ated and trinucleated cells was observed. If massive VEC 
death or cell injury also occurred in vivo, this would be an- 
ticipated to initiate clotting, which is especially disadvanta- 
geous for sickle cell anemia. However, the fact that  the in- 
crease in Na content was transient and  that  the  cells, rather 
than losing K, increased their  cation content after 4  days of 
treatment (Figs 4 and 5) is an indicator of good cell health, 
since dying cells cannot maintain  their  ionic  gradients. Fur- 
thermore, HU has  been shown to heal chronic leg ulcers in 
vivo,2o  which suggests that  the  potentially negative effects of 
the drug  are  a function of dose, length of treatment,  and 
interindividual responses, and  that  by controlling these fac- 
tors its positive effects can be maximized. 
Finally, the HU-induced effects on  the  morphologic and 
functional properties of  VECs,  as  reported  in this study, 
may be caused or accompanied by alterations  in cell mem- 
brane permeability, transformation of endothelial cells, or 
decreased number/density ofVEC  adhesion molecules. Elu- 
cidation of such  mechanisms may have significant impor- 
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